Abstract:Abstract Background Resveratrol is a plant secondary metabolite with diverse, potential health-promoting benefits. Due to its nutraceutical merit, bioproduction of resveratrol via microbial engineering has gained increasing attention and provides an alternative to unsustainable chemical synthesis and straight extraction from plants. However, many studies on microbial resveratrol production were implemented with the addition of water-insoluble phenylalanine or tyrosine-based precursors to the medium, limiting in the sustainable development of bioproduction. Results Here we present a novel coculture platform where two distinct metabolic background species were modularly engineered for the combined total and de novo biosynthesis of resveratrol. In this scenario, the upstream Escherichia coli module is capable of excreting p -coumaric acid into the surrounding culture media through constitutive overexpression of codon-optimized tyrosine ammonia lyase from Trichosporon cutaneum ( TAL ), feedback-inhibition-resistant 3-deoxy-d-arabinoheptulosonate-7-phosphate synthase ( aroG fbr ) and chorismate mutase/prephenate dehydrogenase ( tyrA fbr ) in a transcriptional regulator tyrR knockout strain. Next, to enhance the precursor malonyl-CoA supply, an inactivation-resistant version of acetyl-CoA carboxylase ( ACC1 S659A,S1157A ) was introduced into the downstream Saccharomyces cerevisiae module constitutively expressing codon-optimized 4-coumarate-CoA ligase from Arabidopsis thaliana ( 4CL ) and resveratrol synthase from Vitis vinifera ( STS ), and thus further improve the conversion of p -coumaric acid-to-resveratrol. Upon optimization of the initial inoculation ratio of two populations, fermentation temperature, and culture time, this co-culture system yielded 28.5 mg/L resveratrol from glucose in flasks. In further optimization by increasing initial net cells density at a test tube scale, a final resveratrol titer of 36 mg/L was achieved. Conclusions This is first study that demonstrates the use of a synthetic E. coli – S. cerevisiae consortium for de novo resveratrol biosynthesis, which highlights its potential for production of other p -coumaric-acid or resveratrol derived biochemicals.

Efficient de novo synthesis of resveratrol by metabolically engineered Escherichia coli

Combinatorial optimization of resveratrol production in engineered E. coli.

De Novo Synthesis of Resveratrol from Sucrose by Metabolically Engineered Yarrowia lipolytica

Optimization of Biosynthetical Conditions of Resveratrol with Recombinant Escherichia coli

De novo resveratrol production through modular engineering of an Escherichia coli–Saccharomyces cerevisiae co-culture

Metabolic Engineering of Rhodotorula Toruloides for Resveratrol Production

A Computational Metabolic Model for Engineered Production of Resveratrol in Escherichia coli

Remodelling metabolism for high-level resveratrol production in Yarrowia lipolytica

Heterologous biosynthesis of prenylated resveratrol through multiplex metabolic engineering in Escherichia coli

Engineering the oleaginous yeast Yarrowia lipolytica for high-level resveratrol production

Stepwise Increase of Resveratrol Biosynthesis in Yeast Saccharomyces Cerevisiae by Metabolic Engineering

De novo production of resveratrol from glycerol by engineering different metabolic pathways in Yarrowia lipolytica

Biosynthesis and Engineering of Kaempferol in Saccharomyces Cerevisiae

Strategies for Enhancing Resveratrol Production and the Expression of Pathway Enzymes

Combining Protein and Organelle Engineering for Linalool Overproduction in Saccharomyces Cerevisiae.

Engineering Escherichia Coli for High-Yielding 2,5-Dimethylpyrazine Synthesis from L-Threonine by Reconstructing Metabolic Pathways and Enhancing Cofactors Regeneration

Biosynthesis of resveratrol and piceatannol in engineered microbial strains: achievements and perspectives

Modular Engineering of E. Coli Coculture for Efficient Production of Resveratrol from Glucose and Arabinose Mixture

Synthetic Biology-Driven Microbial Production of Resveratrol: Advances and Perspectives

Redesign and reconstruction of a steviol-biosynthetic pathway for enhanced production of steviol in Escherichia coli

Metabolic Engineering of Escherichia Coli for (2S)-Pinocembrin Production from Glucose by a Modular Metabolic Strategy.